Market Place
Sourcing Support
Mendus to present NK cell program progress at the Innate Killer Summit
19 Mar 2024 //
GLOBENEWSWIRE
The exercise period for warrants of series TO3 commences today
15 Mar 2024 //
GLOBENEWSWIRE
Mendus shareholders declare their intention to exercise warrants of series TO3
15 Mar 2024 //
GLOBENEWSWIRE
Mendus provides business update and outlook for vididencel program
12 Mar 2024 //
GLOBENEWSWIRE
Mendus to participate in upcoming industry conferences
27 Feb 2024 //
GLOBENEWSWIRE
Mendus to hold Business Update event on March 12
23 Feb 2024 //
GLOBENEWSWIRE
Mendus AB Year-end Report for 2023
14 Feb 2024 //
GLOBENEWSWIRE
Invitation to presentation of Mendus™ year-end report for 2023
09 Feb 2024 //
GLOBENEWSWIRE
Mendus to participate in several investor and industry conferences in January
08 Jan 2024 //
GLOBENEWSWIRE
Mendus announces clinical pipeline update
22 Dec 2023 //
GLOBENEWSWIRE
Mendus Ab: Report From The Extraordinary General Meeting
13 Dec 2023 //
GLOBENEWSWIRE
Mendus announces positive survival data from Phase 2 evaluating vididencel
11 Dec 2023 //
GLOBENEWSWIRE
Mendus and Australasian Leukaemia & Lymphoma to expand testing of vididencel
06 Dec 2023 //
GLOBENEWSWIRE
Mendus to Host KOL Event to Review Phase 2 Data with Vididencel
04 Dec 2023 //
GLOBENEWSWIRE
Mendus Announces Nomination Committee for the 2024 Annual General Meeting
17 Nov 2023 //
GLOBENEWSWIRE
NOTICE OF EXTRAORDINARY GENERAL MEETING IN MENDUS AB (PUBL)
13 Nov 2023 //
GLOBENEWSWIRE
Mendus AB Interim Report January September 2023
09 Nov 2023 //
GLOBENEWSWIRE
Mendus presents updated ALISON trial data for vididencel in ovarian cancer
06 Nov 2023 //
GLOBENEWSWIRE
Mendus Phase 1 vididencel clinical trial results in AML
03 Nov 2023 //
GLOBENEWSWIRE
Mendus announces multiple abstracts to be presented at ASH 2023
02 Nov 2023 //
GLOBENEWSWIRE
Mendus to participate in several investor and industry conferences
26 Oct 2023 //
GLOBENEWSWIRE
Mendus will participate in multiple investor and industry conferences
28 Sep 2023 //
GLOBENEWSWIRE
Mendus to present data supporting cancer vaccine platform at CICON23
21 Sep 2023 //
GLOBENEWSWIRE
Mendus Announces Participation in H.C. Wainwright 25th Annual Global Conference
06 Sep 2023 //
GLOBENEWSWIRE
Mendus deltar i flera investerar- och branschkonferenser i september
04 Sep 2023 //
GLOBENEWSWIRE
Mendus to participate in multiple investor and industry conferences in September
04 Sep 2023 //
GLOBENEWSWIRE
Change in number of shares and votes in Mendus AB (publ)
31 Aug 2023 //
GLOBENEWSWIRE
Mendus AB (publ) Interim Report January “ June 2023
29 Aug 2023 //
GLOBENEWSWIRE
Mendus AB (publ) Interim Report January €“ June 2023
29 Aug 2023 //
GLOBENEWSWIRE
Mendus publishes preclinical data demonstrating synergies of ilixadencel
16 Aug 2023 //
GLOBENEWSWIRE
Mendus raises SEK 317 million through the directed issue to Flerie
28 Jul 2023 //
GLOBENEWSWIRE
Mendus publishes prospectus regarding announced rights issue
11 Jul 2023 //
GLOBENEWSWIRE
Report from the extraordinary general meeting of Mendus on 10 July 2023
10 Jul 2023 //
GLOBENEWSWIRE
Mendus appoints NK cell pioneer Lewis Lanier to Scientific Advisory Board
20 Jun 2023 //
GLOBENEWSWIRE
Mendus receives ATMP certificate from European Medicines Agency supporting
19 Jun 2023 //
GLOBENEWSWIRE
Invitation to Mendus™ update on vididencel program as online and on-site events
15 Jun 2023 //
GLOBENEWSWIRE
Mendus presents ADVANCE II immunomonitoring data at the EHA Meeting
12 Jun 2023 //
GLOBENEWSWIRE
Mendus AB: Mendus announces a directed share issue
08 Jun 2023 //
GLOBENEWSWIRE
Mendus AB: Notice of Extraordinary General Meeting in Mendus AB (publ)
08 Jun 2023 //
GLOBENEWSWIRE
Mendus to participate in upcoming conferences in June 2023
25 May 2023 //
GLOBENEWSWIRE
Mendus secures third shareholder loan from Van Herk Investments
17 May 2023 //
GLOBENEWSWIRE
Mendus AB: Mendus AB (publ) Interim Report January – March 2023
12 May 2023 //
GLOBENEWSWIRE
Mendus: Report from the Annual General Meeting of Mendus AB on 12 May 2023
12 May 2023 //
GLOBENEWSWIRE
Mendus announces two upcoming presentations at the EHA2023 Hybrid Congress
11 May 2023 //
GLOBENEWSWIRE
Mendus AB: Change in number of shares and votes in Mendus AB (publ)
28 Apr 2023 //
GLOBENEWSWIRE
Mendus to participate in upcoming conferences in May 2023
27 Apr 2023 //
GLOBENEWSWIRE
Mendus announces two upcoming presentations at the 2023 CIMT Annual Meeting
26 Apr 2023 //
GLOBENEWSWIRE
Mendus announces positive data from the ALISON trial in ovarian cancer
19 Apr 2023 //
GLOBENEWSWIRE
Mendus publishes the Annual Report for 2022 & holds investor call on April 17th
17 Apr 2023 //
GLOBENEWSWIRE
Notice of Annual General Meeting in Mendus AB (publ)
11 Apr 2023 //
GLOBENEWSWIRE
Mendus redeems the outstanding convertible bonds from Negma Group
06 Apr 2023 //
GLOBENEWSWIRE
Mendus to participate in upcoming conferences in April 2023
05 Apr 2023 //
GLOBENEWSWIRE
Mendus announces request for conversion of convertible bonds by Negma Group
04 Apr 2023 //
GLOBENEWSWIRE
Mendus AB: Change in number of shares and votes in Mendus AB (publ)
31 Mar 2023 //
GLOBENEWSWIRE
Mendus announces request for conversion of convertible bonds by Negma Group
31 Mar 2023 //
GLOBENEWSWIRE
Mendus presents an update on the use of its DCOne platform
30 Mar 2023 //
GLOBENEWSWIRE
Mendus announces request for conversion of convertible bonds by Negma Group
30 Mar 2023 //
GLOBENEWSWIRE
Mendus announces request for conversion of convertible bonds by Negma Group
29 Mar 2023 //
GLOBENEWSWIRE
Mendus announces request for conversion of convertible bonds by Negma Group
28 Mar 2023 //
GLOBENEWSWIRE
Mendus announces request for conversion of convertible bonds by Negma Group
27 Mar 2023 //
GLOBENEWSWIRE
